Hottest Stocks
(Over $10)		 Hottest Stocks
($2-$10)		 Biggest Losers
(Over $10)		 Biggest Losers
($2-$10)		 Hottest
Industries		 Hottest
Sectors		 EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for Q Biomed Inc. (QBIO : OTC)
 
 • Company Description   
Q BioMed Inc. is a biomedical acceleration and development company. It focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. Q BioMed Inc. is based in New York.

Number of Employees: 9

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.11 Daily Weekly Monthly
20 Day Moving Average: 339,200 shares
Shares Outstanding: 34.95 (millions)
Market Capitalization: $3.84 (millions)
Beta: 1.43
52 Week High: $1.06
52 Week Low: $0.10
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -40.25% -34.79%
12 Week -72.50% -71.05%
Year To Date -74.42% -70.18%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
366 MADISON AVENUE 3RD FLOOR
-
NEW YORK,NY 10017
USA		 ph: 212-588-0022
fax: -		 None http://www.qbiomed.com
 
 • General Corporate Information   
Officers
Denis Corin - Chief Executive Officer; President and Director
William Rosenstadt - Chief Legal Officer and Director
Rick Panicucci - Director
- - -
- - -

Peer Information
Q Biomed Inc. (CHCR)
Q Biomed Inc. (ESRX)
Q Biomed Inc. (MYDP)
Q Biomed Inc. (GBCS)
Q Biomed Inc. (LAXAF)
Q Biomed Inc. (IPCM)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 74736N105
SIC: 2834
Fiscal Year
Fiscal Year End: November
Last Reported Quarter: 02/01/22
Next Expected EPS Date: 07/21/22
Share - Related Items
Shares Outstanding: 34.95
Most Recent Split Date: (:1)
Beta: 1.43
Market Capitalization: $3.84 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 07/21/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: -
Price / Sales: 14.19
EPS Growth
vs. Year Ago Period: 27.27%
vs. Previous Quarter: 0.00%
Sales Growth
vs. Year Ago Period: -%
vs. Previous Quarter: -28.57%
ROE
02/28/22 - -
11/30/21 - -
08/31/21 - -
ROA
02/28/22 - -1,178.35
11/30/21 - -1,077.83
08/31/21 - -1,337.05
Current Ratio
02/28/22 - 0.03
11/30/21 - 0.08
08/31/21 - 0.07
Quick Ratio
02/28/22 - 0.03
11/30/21 - 0.08
08/31/21 - 0.07
Operating Margin
02/28/22 - -2,971.96
11/30/21 - -
08/31/21 - -
Net Margin
02/28/22 - -2,971.96
11/30/21 - -
08/31/21 - -
Pre-Tax Margin
02/28/22 - -2,972.32
11/30/21 - -4,213.25
08/31/21 - -10,549.45
Book Value
02/28/22 - -0.37
11/30/21 - -0.37
08/31/21 - -0.32
Inventory Turnover
02/28/22 - -
11/30/21 - -
08/31/21 - -
Debt-to-Equity
02/28/22 - -
11/30/21 - -
08/31/21 - -
Debt-to-Capital
02/28/22 - -
11/30/21 - -
08/31/21 - -
 

Powered by Zacks Investment Research ©